Apolipoprotein composition of HDL in cholesteryl ester transfer protein deficiency

Journal of Lipid Research

Volumn 45, Issue 3, 2004, Pages 448-455

  Asztalos, Bela F ^a   Horvath, Katalin V ^a   Kajinami, Kouji ^a   Nartsupha, Chorthip ^a   Cox, Caitlin E ^a   Batista, Marcelo ^a   Schaefer, Ernst J ^a   Inazu, Akihiro ^b   Mabuchi, Hiroshi ^b  

^a TUFTS UNIVERSITY   (United States)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

High density lipoprotein subpopulations; Lipoproteins; Reverse cholesterol transport

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN C; APOLIPOPROTEIN CS; APOLIPOPROTEIN E; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; UNCLASSIFIED DRUG;

ADULT; ANTIATHEROGENIC STATE; ARTICLE; ATHEROGENESIS; CHOLESTEROL ESTER TRANSFER PROTEIN DEFICIENCY; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; COMPOUND HETEROZYGOTE; CONTROLLED STUDY; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; IMMUNOBLOTTING; LIPID COMPOSITION; MALE; NONDENATURING TWO DIMENSIONAL GEL ELECTROPHORESIS; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; TWO DIMENSIONAL GEL ELECTROPHORESIS; ZYGOSITY;

ADULT; APOLIPOPROTEIN A-I; APOLIPOPROTEIN A-II; APOLIPOPROTEINS; APOLIPOPROTEINS A; BIOLOGICAL MARKERS; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; FEMALE; GENOTYPE; GLYCOPROTEINS; HUMANS; LIPOPROTEINS, HDL; MALE; METABOLISM, INBORN ERRORS; MIDDLE AGED;

EID: 1542409274     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M300198-JLR200     Document Type: Article

References (39)

1. Tall, A. 1995. Plasma lipid transfer proteins. Annu. Rev. Biochem. 64:235-257.
2. Lagrost, L. 1994. Regulation of cholesteryl ester transfer protein (CETP) activity: review of in vitro and in vivo studies. Biochim. Biophys. Acta. 1215: 209-236.
3. Quinet, E., A. Tall, R. Ramakrishnan, and L. Rudel. 1991. Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins. J. Clin. Invest. 87: 1559-1566.
4. Fielding, C. J., and P. E. Fielding. 1995. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36: 211-228.
5. Ohta, T., R. Nakamura, K. Takata, Y. Saito, S. Yamashita, S. Horiuchi, and I. Matsuda. 1995. Structural and functional differences of subspecies of apoA-I-containing lipoprotein in patients with plasma cholesteryl ester transfer protein deficiency. J. Lipid Res. 36: 696-704.
6. NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease. 1993. Triglyceride, high-density lipoprotein, and coronary heart disease. J. Am. Med. Assoc. 269: 505-510.
7. Kurasawa, T., S. Yokoyama, Y. Miyake, T. Yamaura, and A. Yamamoto. 1985. Deficiency of serum cholesteryl ester transfer between high and low density lipoproteins in human serum and a case with decreased transfer rate in association with hyperalphalipoproteinemia. J. Biochem. 98: 1499-1508.
8. Koizumi, J., H. Mabuchi, A. Yoshimura, I. Michishita, M. Takeda, H. Itoh, Y. Sakai, T. Sakai, K. Ueda, and R. Takeda. 1985. Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinemia. Atherosclerosis. 58: 175-186.
9. Inazu, A., M. L. Brown, C. B. Hesler, L. B. Agellon, J. Koizumi, K. Takata, Y. Maruhama, H. Mabuchi, and A. R. Tall. 1990. Increased high-density lipoprotein levels caused by a common cholesterylester transfer protein gene mutation. N. Engl. J. Med. 323: 1234-1238.
10. Arai, T., T. Tsukada, T. Murase, and K. Matsumoto. 2000. Particle size analysis of high density lipoproteins in patients with genetic cholesteryl ester transfer protein deficiency. Clin. Chim. Acta. 301: 103-117.
11. Ishigami, M., S. Yamashita, N. Sakai, T. Arai, K. Hirano, H. Hiraoka, K. Kameda-Takemura, and Y. Matsuzama. 1994. Large and cholesteryl ester-rich high-density lipoproteins in cholesteryl ester transfer protein (CETP) deficiency can not protect macrophages from cholesterol accumulation induced by acetylated low-density lipoproteins. J. Biochem. 116: 257-262.
12. Inazu, A., X. C. Jiang, T. Haraki, K. Yagi, N. Kamon, J. Koizumi, H. Mabuchi, R. Takeda, K. Takata, Y. Moriyama, M. Doi, and A. Tall. 1994. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J. Clin. Invest. 94: 1872-1882.
13. Inazu, A., J. Koizumi, T. Haraki, K. Yagi, T. Wakasugi, T. Takegoshi, H. Mabuchi, and R. Takeda. 1993. Rapid detection and prevalence of cholesteryl ester transfer protein deficiency caused by an intron 14 splicing defect in hyperalpha-lipoproteinemia. Hum. Genet. 91: 13-16.
14. Hirano, K, S. Yamashita, T. Funahashi, N. Sakai, M. Menju, M. Ishigami, H. Hiraoka, K. Kameda-Takemura, K. Tokugana, and T. Hoshino. 1993. Frequency of intron 14 splicing defect of cholesteryl ester transfer protein gene in the Japanese general population: relation between the mutation and hyperalphalipoproteinemia. Atherosclerosis. 100: 85-90.
15. Sakai, N., S. Yamashita, K. Hirano, M. Menju, T. Arai, K. Kobayashi, M. Ishigami, Y. Yoshida, T. Hoshino, and N. Nakajima. 1995. Frequency of exon 15 missense mutation (442D:G) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects. Atherosclerosis. 114: 139-145.
16. Hirano, K., S. Yamashita, N. Nakajima, T. Arai, T. Maruyama, Y. Yoshida, M. Ishigami, N. Sakai, K. Kameda-Takemura, and Y. Matsuzawa. 1997. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Arterioscler. Thromb. Vasc. Biol. 17: 1053-1059.
17. Hirano, K., Y. Matsuzawa, N. Sakai, H. Hiraoka, S. Nozaki, T. Funahashi, S. Yamashita, M. Kubo, and S. Tarui. 1992. Polydisperse low-density lipoproteins in hyperalphalipoproteinemic chronic alcohol drinkers in association with marked reduction of cholesteryl ester transfer protein activity. Metabolism. 41: 1313-1318.
18. Kakko, S., M. Tamminen, M. Paivansalo, H. Kauma, A. O. Rantala, M. Lilja, A. Reunanen, Y. A. Kesaniemi, and M.J. Savolainen. 2000. Cholesteryl ester transfer protein gene polymorphisms are associated with carotid atherosclerosis in men. Eur. J. Clin. Invest. 30: 18-25.
19. Barter, P.J., B. H. Brewer, J. M. Chapman, C. H. Hennekens, D. J. Rader, and A. R. Tall. 2002. Cholesteryl ester transfer protein. A novel target for raising HDL and inhibiting atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 23: 160-167.
20. Asztalos, B. F., C. H. Sloop, L. Wong, and P. S. Roheim. 1993. Two-dimensional electrophoresis of plasma lipoproteins: recognition of new apoA-I-containing subpopulations. Biochim. Biophys. Acta. 1169:291-300.
21. Asztalos, B. F., M. Lefevre, T. A. Foster, R. Tulley, M. Windhauser, L. Wong, and P. S. Roheim. 1997. Normolipidemic subjects with low HDL cholesterol levels have altered HDL subpopulations. Arterioscler. Thromb. Vasc. Biol. 17: 1885-1893.
22. Johnson, R. F., S. C. Pickett, and B. L. Barker. 1990. Autoradiography using storage phosphor technology. Electrophoresis. 11: 355-360.
23. Yamashita, S., D. L. Sprecher, N. Sakai, Y. Matsuzawa, S. Tarui, and D. Y. Huy. 1990. Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with deficiency of cholesteryl ester transfer protein. J. Clin. Invest. 86:688-695.
24. Asztalos, B. F., K. V. Horvath, J. R. McNamara, P. S. Roheim, J. J. Rubinstein, and E. J. Schaefer. 2002. Effects of atorvastatin on the HDL subpopulation profile of coronary heart disease patients. J. Lipid Res. 43: 1701-1707.
25. Asztalos, B. F., K. V. Horvath, J. R. McNamara, P. S. Roheim, J. J. Rubinstein, and E. J. Schaefer. 2002. Comparing the effects of five different statins on the HDL subpopulation profiles of coronary heart disease patients. Atherosclerosis. 164: 361-369.
26. Guerin, M., T. S. Lassel, W. Le Goff, M. Farnier, and M. J. Chapman. 2000. Action of atorvastatin in combined hyperlipidemia: preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles. Arterioscler. Thromb. Vasc. Biol. 20: 189-197.
27. Okamoto, H., F. Yonemori, K. Wakitani, T. Minowa, K. Maeda, and H. Shinkai. 2000. A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits. Nature. 406: 203-207.
28. de Grooth, G. J., J. A. Kuivenhoven, A. F. H. Stalenhoef, J. De Graaf, A. H. Zwinderman, J. L. Posma, A. van Tol, and J. J. P. Kastelein. 2002. Efficacy and safety of novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans. A randomized phase II dose-response study. Circulation. 105: 2159-2165.
29. Asztalos, B. F., P. S. Roheim, R. L. Milani, M. Lefevre, J. R. Mc-Namara, K. V. Horvath, and E. J. Schaefer. 2000. Distribution of apoA-I-containing HDL subpopulations in patients with coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 20: 2670-2676.
30. Asztalos, B. F., M. E. Brousseau, J. R. McNamara, K. V. Horvath, P. S. Roheim, and E. J. Schaefer. 2001. Subpopulations of high density lipoproteins in homozygous and heterozygous Tangier disease. Atherosclerosis. 156: 217-225.
31. Asztalos, B. F., M. Batista, K. V. Horvath, C. E. Cox, G. E. Dallal, J. S. Morse, G. B. Brown, and E. J. Schaefer. 2003. Change in α-1 HDL concentration predicts progression in coronary artery stenosis. Arterioscler. Thromb. Vasc. Biol. 23: 847-852.
32. Duverger, N., D. Rader, K. Ikewaki, M. Nishiwaki, T. Sakamoto, T. Ishikawa, M. Nagano, H. Nakamura, and H. B. Brewer. 1995. Characterization of high-density apolipoprotein particles A-I and A-I:A-II isolated from humans with cholesteryl ester transfer protein deficiency. Eur. J. Biochem. 227: 123-129.
33. Chiba, H., H. Akita, K. Tsuchihashi, S. P. Hui, Y. Takahasi, H. Fuda, H. Suzuki, H. Shibuya, M. Tsuji, and K. Kobayashi. 1997. Quantitative and compositional changes in high density lipoprotein subclasses in patients with various genotypes of cholesteryl ester transfer protein deficiency. J. Lipid Res. 38: 1204-1216.
34. Hannuksela, M. L., M. E. Brousseau, S. M. Meyn, H. Nahiz, G. Bader, R. D. Shamburek, P. Alaupovic, and H. B. Brewer. 2002. In vivo metabolism of apolipoprotein E with the HDL subpopulations LpE, LpE:A-I, LpE:A-II, and LpE:A-I:A-II. Atherosclerosis. 165: 205-220.
35. Jong, M. C., M. H. Hofker, and L. M. Havakes. 1999. Role of apoCs in lipoprotein metabolism. Functional differences between apoC1, apoC2, and apoC3. Arterioscler. Thromb. Vasc. Biol. 19: 472-484.
36. Settasatian, N., N. Duong, L. Curtiss, C. Ehnholm, M. Jauhiainen, J. Huuskonen, and K. A. Rye. 2001. The mechanism of the remodeling of high density lipoproteins by phospholipid transfer protein. J. Biol. Chem. 276: 26898-26905.
37. Fidge, N. H. 1999. High density lipoprotein receptors, binding proteins, and ligand. J. Lipid Res. 40: 187-201.
38. deBeer, M. C., D. M. Durbin, L. Cai, N. Mirocha, A. Jonas, N. R. Webb, F. C. deBeer, and D. R. van der Westhuyzen. 2001. Apolipoprotein A-II modulates the binding and selective lipid uptake of reconstituted high density lipoprotein by scavenger receptor B1. J. Biol. Chem. 276: 15832-15839.
39. Bisgaier, C. L., M. V. Siebenkas, M. L. Brown, A. Inazu, J. Koizumi, H. Mabuchi, and A. R. Tall. 1991. Familial cholesteryl ester transfer protein deficiency is associated with triglyceride-rich low density lipoproteins containing cholesteryl esters of probable intracellular origin. J. Lipid Res. 32: 21-33.